Results 251 to 260 of about 1,587,544 (388)
Biosynthesis of Fatty Acids by a Soluble Extract From Developing Soybean Cotyledons [PDF]
Robert W. Rinne
openalex +1 more source
PDAC has a poor prognosis due to chemoresistance. We revealed that MCU upregulation is associated with chemoresistance and stemness in PDAC. MCU‐mediated Ca2+ influx induced ER stress, activating the PERK‐ATF4/NRF2 axis to enhance PSAT1/SLC711 expression and glutathione synthesis, reducing ROS and maintaining stemness.
Zekun Li +17 more
wiley +1 more source
Identification and characterization of the class III peroxidase gene family in sea buckthorn (Hippophae rhamnoides subsp. sinensis Rousi) and its potential role in lignin biosynthesis. [PDF]
Zhao J +6 more
europepmc +1 more source
Participation of peroxisomes in lipid biosynthesis in the harderian gland of guinea pig [PDF]
Seichi Horie, Takuya Suga
openalex +1 more source
Biosynthesis of zinc oxide nanoparticles as a potential adsorbent for degrading organochlorines
C.O. Ondijo, O. K’owino, F.O. Kengara
openalex +2 more sources
Oxidative phosphorylation (OXPHOS) activity serves as a critical metabolic determinant of radiotherapy outcomes in esophageal squamous cell carcinoma (ESCC). The CEBPB/AREG/EREG axis drives radioresistance in ESCC by reprogramming OXPHOS. AREG and EREG function as predictive biomarkers for nCRT response and prognosis of ESCC patients.
Zhang Lin +15 more
wiley +1 more source
PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao +16 more
wiley +1 more source
MIF-expressing tumor cells mediate immunotherapeutic resistance in esophageal squamous cell carcinoma. [PDF]
Song J, Song X, Xie Y, Guo H, Cun Y.
europepmc +1 more source

